Crotamiton is a scabicidal and antipruritic agent available as a cream or lotion for topical use. The drug was approved by FDA for the treatment of scabies and pruritic skin. Crotamiton is a mixture of the cis and trans isomers of N-ethyl-N-(o-methylphenyl)-2butenamide. Although the activity of crotamiton was shown both in vitro and in vivo, the mechanism of its action is still unknown.
Originator
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Curative | EURAX Approved UseFor eradication of scabies (Sarcoptes scabiei) and for symptomatic treatment of pruritic skin. Launch Date1949 |
|||
| Palliative | EURAX Approved UseFor eradication of scabies (Sarcoptes scabiei) and for symptomatic treatment of pruritic skin. Launch Date1949 |
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
24.5 ng/mL |
500 mg single, topical dose: 500 mg route of administration: Topical experiment type: SINGLE co-administered: |
CROTAMITON plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
344 ng × h/mL |
500 mg single, topical dose: 500 mg route of administration: Topical experiment type: SINGLE co-administered: |
CROTAMITON plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Topical ivermectin versus crotamiton cream 10% for the treatment of scabies. | 2014-07 |
|
| Treatment of scabies, permethrin 5% cream vs. crotamiton 10% cream. | 2013 |
|
| Chromatography of crotamiton and its application to the determination of active ingredients in ointments. | 1997-06 |
|
| Contact dermatitis from crotamiton. | 1992-07 |
|
| The sensitizing capacity of crotamiton. | 1988-05 |
|
| Treatment of scabies with crotamiton. | 1988-05 |
|
| Contact dermatitis due to crotamiton. | 1986-10 |
|
| Crotamiton lotion in pruritus. | 1984-12 |
|
| A single application of crotamiton lotion in the treatment of patients with pediculosis capitis. | 1982-12 |
|
| Crotamiton cream and lotion in the treatment of infants and young children with scabies. | 1979 |
|
| [Crotamiton and crotamiton hydrocortisone compounds in the treatment of pruritus]. | 1965-08-20 |
|
| The use of N-ethyl-o-crotonotoluidide in the treatment of scabies and various pruritic dermatoses. | 1949-07 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QP53AX04
Created by
admin on Mon Mar 31 22:05:43 GMT 2025 , Edited by admin on Mon Mar 31 22:05:43 GMT 2025
|
||
|
NCI_THESAURUS |
C28394
Created by
admin on Mon Mar 31 22:05:43 GMT 2025 , Edited by admin on Mon Mar 31 22:05:43 GMT 2025
|
||
|
EPA PESTICIDE CODE |
55701
Created by
admin on Mon Mar 31 22:05:43 GMT 2025 , Edited by admin on Mon Mar 31 22:05:43 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C005553
Created by
admin on Mon Mar 31 22:05:43 GMT 2025 , Edited by admin on Mon Mar 31 22:05:43 GMT 2025
|
PRIMARY | |||
|
673
Created by
admin on Mon Mar 31 22:05:43 GMT 2025 , Edited by admin on Mon Mar 31 22:05:43 GMT 2025
|
PRIMARY | |||
|
1151006
Created by
admin on Mon Mar 31 22:05:43 GMT 2025 , Edited by admin on Mon Mar 31 22:05:43 GMT 2025
|
PRIMARY | |||
|
758951
Created by
admin on Mon Mar 31 22:05:43 GMT 2025 , Edited by admin on Mon Mar 31 22:05:43 GMT 2025
|
PRIMARY | |||
|
m3855
Created by
admin on Mon Mar 31 22:05:43 GMT 2025 , Edited by admin on Mon Mar 31 22:05:43 GMT 2025
|
PRIMARY | Merck Index | ||
|
CROTAMITON
Created by
admin on Mon Mar 31 22:05:43 GMT 2025 , Edited by admin on Mon Mar 31 22:05:43 GMT 2025
|
PRIMARY | |||
|
DB00265
Created by
admin on Mon Mar 31 22:05:43 GMT 2025 , Edited by admin on Mon Mar 31 22:05:43 GMT 2025
|
PRIMARY | |||
|
744
Created by
admin on Mon Mar 31 22:05:43 GMT 2025 , Edited by admin on Mon Mar 31 22:05:43 GMT 2025
|
PRIMARY | |||
|
D6S4O4XD0H
Created by
admin on Mon Mar 31 22:05:43 GMT 2025 , Edited by admin on Mon Mar 31 22:05:43 GMT 2025
|
PRIMARY | |||
|
21766
Created by
admin on Mon Mar 31 22:05:43 GMT 2025 , Edited by admin on Mon Mar 31 22:05:43 GMT 2025
|
PRIMARY | RxNorm | ||
|
SUB06828MIG
Created by
admin on Mon Mar 31 22:05:43 GMT 2025 , Edited by admin on Mon Mar 31 22:05:43 GMT 2025
|
PRIMARY | |||
|
207-596-3
Created by
admin on Mon Mar 31 22:05:43 GMT 2025 , Edited by admin on Mon Mar 31 22:05:43 GMT 2025
|
PRIMARY | |||
|
483-63-6
Created by
admin on Mon Mar 31 22:05:43 GMT 2025 , Edited by admin on Mon Mar 31 22:05:43 GMT 2025
|
PRIMARY | |||
|
DTXSID6040664
Created by
admin on Mon Mar 31 22:05:43 GMT 2025 , Edited by admin on Mon Mar 31 22:05:43 GMT 2025
|
PRIMARY | |||
|
crotamiton
Created by
admin on Mon Mar 31 22:05:43 GMT 2025 , Edited by admin on Mon Mar 31 22:05:43 GMT 2025
|
PRIMARY | |||
|
100000083722
Created by
admin on Mon Mar 31 22:05:43 GMT 2025 , Edited by admin on Mon Mar 31 22:05:43 GMT 2025
|
PRIMARY | |||
|
CHEMBL1200709
Created by
admin on Mon Mar 31 22:05:43 GMT 2025 , Edited by admin on Mon Mar 31 22:05:43 GMT 2025
|
PRIMARY | |||
|
D6S4O4XD0H
Created by
admin on Mon Mar 31 22:05:43 GMT 2025 , Edited by admin on Mon Mar 31 22:05:43 GMT 2025
|
PRIMARY | |||
|
C65353
Created by
admin on Mon Mar 31 22:05:43 GMT 2025 , Edited by admin on Mon Mar 31 22:05:43 GMT 2025
|
PRIMARY | |||
|
31439
Created by
admin on Mon Mar 31 22:05:43 GMT 2025 , Edited by admin on Mon Mar 31 22:05:43 GMT 2025
|
PRIMARY |
All of the following components must be present:
ACTIVE MOIETY